{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:22:21Z","timestamp":1794979341240,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370177"],"award-info":[{"award-number":["32370177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH302"],"award-info":[{"award-number":["ZR2020MH302"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MC020"],"award-info":[{"award-number":["ZR2020MC020"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1038\/s41416-025-03131-0","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T18:17:58Z","timestamp":1754763478000},"page":"1085-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["LMP2A regulates S901 phosphorylation of EphA2 to maintain EBV latent infection in gastric cancer"],"prefix":"10.1038","volume":"133","author":[{"given":"Duo","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-5958","authenticated-orcid":false,"given":"Bing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"3131_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: a cancer J Clin."},{"key":"3131_CR2","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","DOI":"10.1038\/nature13480"},{"key":"3131_CR3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gutjnl-2013-304531","volume":"63","author":"MC Camargo","year":"2014","unstructured":"Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 2014;63:236\u201343.","journal-title":"Gut"},{"key":"3131_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2014.09.020","volume":"148","author":"SY Kim","year":"2015","unstructured":"Kim SY, Park C, Kim HJ, Park J, Hwang J, Kim JI, et al. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Gastroenterology 2015;148:137\u201347.e9.","journal-title":"Gastroenterology"},{"key":"3131_CR5","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","volume":"91","author":"S Imai","year":"1994","unstructured":"Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994;91:9131\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3131_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","volume":"495","author":"J Yang","year":"2020","unstructured":"Yang J, Liu Z, Zeng B, Hu G, Gan R. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett. 2020;495:191\u20139.","journal-title":"Cancer Lett."},{"key":"3131_CR7","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.03639-14","volume":"89","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, et al. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis. J Virol. 2015;89:5581\u201391.","journal-title":"J Virol."},{"key":"3131_CR8","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1038\/emm.2014.84","volume":"47","author":"MS Kang","year":"2015","unstructured":"Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med. 2015;47:e131.","journal-title":"Exp Mol Med."},{"key":"3131_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11262-019-01705-8","volume":"55","author":"J Needham","year":"2019","unstructured":"Needham J, Adamson AL. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines. Virus genes 2019;55:779\u201385.","journal-title":"Virus genes"},{"key":"3131_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","volume":"12","author":"H Li","year":"2016","unstructured":"Li H, Liu S, Hu J, Luo X, Li N, Bode AM, et al. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci. 2016;12:1309\u201318.","journal-title":"Int J Biol Sci."},{"key":"3131_CR11","volume":"15","author":"LA Murray-Nerger","year":"2024","unstructured":"Murray-Nerger LA, Lozano C, Burton EM, Liao Y, Ungerleider NA, Guo R, et al. The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression. Nat Commun. 2024;15:4156.","journal-title":"Nat Commun."},{"key":"3131_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1349-7006.2005.00007.x","volume":"96","author":"R Nakamura","year":"2005","unstructured":"Nakamura R, Kataoka H, Sato N, Kanamori M, Ihara M, Igarashi H, et al. EPHA2\/EFNA1 expression in human gastric cancer. Cancer Sci. 2005;96:42\u20137.","journal-title":"Cancer Sci."},{"key":"3131_CR13","volume":"6","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Yamada N, Tanaka T, Hori T, Yokoyama S, Hayakawa Y, et al. Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2. Nat Commun. 2015;6:7679.","journal-title":"Nat Commun."},{"key":"3131_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2009.04.009","volume":"16","author":"H Miao","year":"2009","unstructured":"Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009;16:9\u201320.","journal-title":"Cancer Cell"},{"key":"3131_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","volume":"3","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, et al. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol. 2018;3:1\u20138.","journal-title":"Nat Microbiol."},{"key":"3131_CR16","doi-asserted-by":"crossref","first-page":"e3001392","DOI":"10.1371\/journal.pbio.3001392","volume":"19","author":"TP Light","year":"2021","unstructured":"Light TP, Brun D, Guardado-Calvo P, Pederzoli R, Haouz A, Neipel F, et al. Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling. PLoS Biol. 2021;19:e3001392.","journal-title":"PLoS Biol."},{"key":"3131_CR17","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.01392-14","volume":"88","author":"AS Hahn","year":"2014","unstructured":"Hahn AS, Desrosiers RC. Binding of the Kaposi\u2019s sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule. J. Virol. 2014;88:8724\u201334.","journal-title":"J. Virol."},{"key":"3131_CR18","doi-asserted-by":"crossref","first-page":"e1011304","DOI":"10.1371\/journal.ppat.1011304","volume":"19","author":"XD Dong","year":"2023","unstructured":"Dong XD, Li Y, Li Y, Sun C, Liu SX, Duan H, et al. EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS Pathog. 2023;19:e1011304.","journal-title":"PLoS Pathog."},{"key":"3131_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med. 2011;17:589\u201395.","journal-title":"Nat Med."},{"key":"3131_CR20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.13048","volume":"26","author":"JH Tian","year":"2019","unstructured":"Tian JH, Liu WD, Zhang ZY, Tang LH, Li D, Tian ZJ, et al. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. J Viral Hepat. 2019;26:496\u2013505.","journal-title":"J Viral Hepat."},{"key":"3131_CR21","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/jvi.70.10.7260-7263.1996","volume":"70","author":"N Shimizu","year":"1996","unstructured":"Shimizu N, Yoshiyama H, Takada K. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol. 1996;70:7260\u20133.","journal-title":"J Virol."},{"key":"3131_CR22","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/jvi.71.7.5688-5691.1997","volume":"71","author":"H Yoshiyama","year":"1997","unstructured":"Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol. 1997;71:5688\u201391.","journal-title":"J Virol."},{"key":"3131_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jgg.2021.02.011","volume":"48","author":"P Zhao","year":"2021","unstructured":"Zhao P, Jiang D, Huang Y, Chen C. EphA2: A promising therapeutic target in breast cancer. J Genet genomics = Yi chuan xue bao 2021;48:261\u20137.","journal-title":"J Genet genomics = Yi chuan xue bao"},{"key":"3131_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13533-7","volume":"7","author":"M Granato","year":"2017","unstructured":"Granato M, Romeo MA, Tiano MS, Santarelli R, Gonnella R, Gilardini Montani MS, et al. Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy. Sci Rep. 2017;7:13052.","journal-title":"Sci Rep."},{"key":"3131_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","volume":"26","author":"SC Kenney","year":"2014","unstructured":"Kenney SC, Mertz JE. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol. 2014;26:60\u20138.","journal-title":"Semin Cancer Biol."},{"key":"3131_CR26","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: Biology and clinical disease. Cell 2022;185:3652\u201370.","journal-title":"Cell"},{"key":"3131_CR27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3324\/haematol.2010.023689","volume":"95","author":"A Merlo","year":"2010","unstructured":"Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, et al. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica 2010;95:1769\u201377.","journal-title":"Haematologica"},{"key":"3131_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/jvi.63.1.445-449.1989","volume":"63","author":"K Takada","year":"1989","unstructured":"Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989;63:445\u20139.","journal-title":"J Virol."},{"key":"3131_CR29","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1128\/JVI.01197-10","volume":"85","author":"T Iempridee","year":"2011","unstructured":"Iempridee T, Das S, Xu I, Mertz JE. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. J Virol. 2011;85:7836\u201348.","journal-title":"J Virol."},{"key":"3131_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol. 2005;15:3\u201315.","journal-title":"Rev Med Virol."},{"key":"3131_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","volume":"15","author":"W Amon","year":"2005","unstructured":"Amon W, Farrell PJ. Reactivation of Epstein-Barr virus from latency. Rev Med Virol. 2005;15:149\u201356.","journal-title":"Rev Med Virol."},{"key":"3131_CR32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cncr.26184","volume":"118","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jin H, Cheung KF, Tong JH, Zhang S, Go MY, et al. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Cancer 2012;118:924\u201336.","journal-title":"Cancer"},{"key":"3131_CR33","doi-asserted-by":"crossref","unstructured":"Kraus RJ, Cordes BA, Sathiamoorthi S, Patel P, Yuan X, Iempridee T, et al. Reactivation of Epstein-Barr Virus by HIF-1\u03b1 Requires p53. J Virol. 2020;94:e00722\u201320.","DOI":"10.1128\/JVI.00722-20"},{"key":"3131_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 2010;10:165\u201380.","journal-title":"Nat. Rev. Cancer"},{"key":"3131_CR35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11262-023-02023-w","volume":"59","author":"D Shi","year":"2023","unstructured":"Shi D, Liu W, Zhang X, Zhang Y, Luo B. MiR-BART1-3p and BART18-5p inhibit cell migration, proliferation and activate autophagy in Epstein-Barr virus-associated gastric cancer by targeting erythropoietin-producing human hepatocellular 2. Virus genes 2023;59:703\u201315.","journal-title":"Virus genes"},{"key":"3131_CR36","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","volume":"40","author":"L Mao","year":"2021","unstructured":"Mao L, Yuan W, Cai K, Lai C, Huang C, Xu Y, et al. EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene 2021;40:3610\u201323.","journal-title":"Oncogene"},{"key":"3131_CR37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/ijc.32609","volume":"146","author":"C Huang","year":"2020","unstructured":"Huang C, Yuan W, Lai C, Zhong S, Yang C, Wang R, et al. EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. Int J Cancer 2020;146:1937\u201349.","journal-title":"Int J Cancer"},{"key":"3131_CR38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tcb.2017.01.003","volume":"27","author":"AV Zamaraev","year":"2017","unstructured":"Zamaraev AV, Kopeina GS, Prokhorova EA, Zhivotovsky B, Lavrik IN. Post-translational Modification of Caspases: The Other Side of Apoptosis Regulation. Trends cell Biol. 2017;27:322\u201339.","journal-title":"Trends cell Biol."},{"key":"3131_CR39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793\u2013805.","journal-title":"Nat Rev Cancer"},{"key":"3131_CR40","doi-asserted-by":"crossref","unstructured":"Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2012;40:D71-5.","DOI":"10.1093\/nar\/gkr981"},{"key":"3131_CR41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","volume":"127","author":"JV Olsen","year":"2006","unstructured":"Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006;127:635\u201348.","journal-title":"Cell"},{"key":"3131_CR42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/BST0370627","volume":"37","author":"LN Johnson","year":"2009","unstructured":"Johnson LN. The regulation of protein phosphorylation. BioChemical Soc Trans. 2009;37:627\u201341.","journal-title":"BioChemical Soc Trans."},{"key":"3131_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109668","volume":"73","author":"MP Gehring","year":"2020","unstructured":"Gehring MP, Pasquale EB. Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains. Cell Signal 2020;73:109668.","journal-title":"Cell Signal"},{"key":"3131_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2018.12.011","volume":"444","author":"JY Li","year":"2019","unstructured":"Li JY, Xiao T, Yi HM, Yi H, Feng J, Zhu JF, et al. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties. Cancer Lett. 2019;444:162\u201374.","journal-title":"Cancer Lett."},{"key":"3131_CR45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/thy.2019.0728","volume":"31","author":"C Allocca","year":"2021","unstructured":"Allocca C, Cirafici AM, Laukkanen MO, Castellone MD. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1\/2 Drivers in Thyroid Cancer Cells. Thyroid : J Am Thyroid Assoc. 2021;31:76\u201387.","journal-title":"Thyroid : J Am Thyroid Assoc."},{"key":"3131_CR46","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41416-022-01914-3","volume":"127","author":"A Sachdeva","year":"2022","unstructured":"Sachdeva A, Hart CA, Kim K, Tawadros T, Oliveira P, Shanks J, et al. Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. Br J Cancer 2022;127:1254\u201362.","journal-title":"Br J Cancer"},{"key":"3131_CR47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41419-020-02831-0","volume":"11","author":"YP Xiang","year":"2020","unstructured":"Xiang YP, Xiao T, Li QG, Lu SS, Zhu W, Liu YY, et al. Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2\/Erk-1\/2 signaling pathway. Cell Death Dis. 2020;11:709.","journal-title":"Cell Death Dis."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03131-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:23:57Z","timestamp":1760624637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["3131"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03131-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was obtained from the Institutional Review Board of Qingdao University. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study, participants signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}